UB Paderborn / Katalog / Suche / in CDI

Genetic Modification Strategies to Enhance CAR T Cell Persistence for Patients With Solid Tumors

Frontiers in immunology, 2019-02, Vol.10, p.218-218

2019

Link zum Volltext

Verfügbarkeit prüfen

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

Nature communications, 2020-07, Vol.11 (1), p.3549-3549, Article 3549

2020

Link zum Volltext

Verfügbarkeit prüfen

CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives

EJC paediatric oncology, 2024-06, Vol.3, p.100160, Article 100160

2024

Link zum Volltext

Verfügbarkeit prüfen

A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCα activation

Journal of experimental & clinical cancer research, 2024-04, Vol.43 (1), p.97-97, Article 97

2024

Link zum Volltext

Verfügbarkeit prüfen

A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells

Frontiers in immunology, 2021-06, Vol.12, p.691741-691741

2021

Link zum Volltext

Verfügbarkeit prüfen

Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells

Molecular therapy. Oncolytics, 2020-09, Vol.18, p.202-214

2020

Link zum Volltext

Verfügbarkeit prüfen

CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?

Molecular therapy, 2020-11, Vol.28 (11), p.2320-2339

2020

Link zum Volltext

Verfügbarkeit prüfen

263 Unveiling the role of macrophages in CAR T-cell induced remodeling of the brain tumor immune microenvironment: implications for anti-glioma adoptive immunotherapy

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A303-A303

2023

Link zum Volltext

Verfügbarkeit prüfen

CD47 expression is critical for CAR T-cell survival in vivo

Journal for immunotherapy of cancer, 2023-03, Vol.11 (3), p.e005857

2023

Link zum Volltext

Verfügbarkeit prüfen

Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s

Advances in experimental medicine and biology, 2020, Vol.1257, p.109-131

2020

Link zum Volltext

Verfügbarkeit prüfen

P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms

International journal of oncology, 2013-12, Vol.43 (6), p.1817-1823

2013

Link zum Volltext

Verfügbarkeit prüfen

Genetically modified T-cell therapy for osteosarcoma

Advances in experimental medicine and biology, 2014, Vol.804, p.323

2014

Link zum Volltext

Verfügbarkeit prüfen

Antigen-dependent costimulation to improve T-cell therapy for cancer

Journal of clinical oncology, 2017-03, Vol.35 (7_suppl), p.151-151

2017

Link zum Volltext

Verfügbarkeit prüfen

cBAF complex components and MYC cooperate early in CD8 + T cell fate

Nature (London), 2022-07, Vol.607 (7917), p.135-141

2022

Link zum Volltext

Verfügbarkeit prüfen

A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKC[alpha] activation

Journal of experimental & clinical cancer research, 2024-04, Vol.43 (1)

2024

Link zum Volltext

Verfügbarkeit prüfen

Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery

Neuro-oncology (Charlottesville, Va.), 2021-06, Vol.23 (6), p.999-1011

2021

Link zum Volltext

Verfügbarkeit prüfen

Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma

Pediatric blood & cancer, 2019-01, Vol.66 (1), p.e27469-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid Tumors

American Society of Clinical Oncology educational book, 2018-05, Vol.38 (38), p.830-837

2018

Link zum Volltext

Verfügbarkeit prüfen

Preparation of cryopreserved chimeric antigen receptor T cells for the locoreogional delivery to the neural axis

Cytotherapy (Oxford, England), 2023-11, Vol.25 (11), p.1149-1154

2023

Link zum Volltext

Verfügbarkeit prüfen

AUTOSHAPING OF ETHANOL DRINKING: AN ANIMAL MODEL OF BINGE DRINKING

Alcohol and alcoholism (Oxford), 2002-03, Vol.37 (2), p.138-146

2002

Link zum Volltext

Verfügbarkeit prüfen

De novo DNA methylation programs regulate CAR T-cell exhaustion

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.246-246.5

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-147: Administration of HER2-CAR T cells after lymphodepletion safely improves T cell expansion and induces clinical responses in patients with advanced sarcomas

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.LB-147-LB-147

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1197: B7-H3-CAR T cells for the treatment of pediatric adrenocortical carcinoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1197-1197

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1778: B7-H3-CAR T-cell therapy in immune-competent osteosarcoma models: Regnase-1 KO overcomes limited CAR T-cell expansion

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1778-1778

2023

Link zum Volltext

Verfügbarkeit prüfen

CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity

Cancer research communications, 2023-12, Vol.3 (12), p.2430-2446

2023

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Genetic Modification Strategies to Enhance CAR T Cell Persistence for Patients With Solid Tumors

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives

A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCα activation

A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells

Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells

CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?

263 Unveiling the role of macrophages in CAR T-cell induced remodeling of the brain tumor immune microenvironment: implications for anti-glioma adoptive immunotherapy

CD47 expression is critical for CAR T-cell survival in vivo

Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s

P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms

Genetically modified T-cell therapy for osteosarcoma

Antigen-dependent costimulation to improve T-cell therapy for cancer

cBAF complex components and MYC cooperate early in CD8 + T cell fate

A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKC[alpha] activation

Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery

Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma

The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid Tumors

Preparation of cryopreserved chimeric antigen receptor T cells for the locoreogional delivery to the neural axis

AUTOSHAPING OF ETHANOL DRINKING: AN ANIMAL MODEL OF BINGE DRINKING

De novo DNA methylation programs regulate CAR T-cell exhaustion

Abstract LB-147: Administration of HER2-CAR T cells after lymphodepletion safely improves T cell expansion and induces clinical responses in patients with advanced sarcomas

Abstract 1197: B7-H3-CAR T cells for the treatment of pediatric adrenocortical carcinoma

Abstract 1778: B7-H3-CAR T-cell therapy in immune-competent osteosarcoma models: Regnase-1 KO overcomes limited CAR T-cell expansion

CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity

Suchergebnisse filtern